-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Fire in Northern China Apartment Building Kills 14
-
Solihull Hospital Performs First Robotic-Assisted Gynaecological Cancer Surgeries
-
Apple’s 20th Anniversary iPhone to Skip Action Button for Camera Control Integration
-
Nvidia CEO Jensen Huang Admits Infidelity Amid Spy Investigation
-
Family of Woman Who Died at Voting Station Condemns Official Silence
-
Ted Scheinman’s Journey Through Depression and Electroconvulsive Therapy
-
Karen Wazen Launches First Standalone Boutiques in Cairo
-
Phoenix Symphony Resumes Performances Amid Financial Uncertainty
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
Top Chef Winner Nicole Gomes Opens Lucky Lily Asian Brasserie at YVR
-
First Drive: 2027 BMW i760 xDrive Review
-
Marc Almond to Close Soft Cell Era After Final 'Danceteria' Tour
-
Gary, Indiana Blackout Exposes FEMA Relief Disparities Along Racial Lines
-
Malta Chamber of Commerce and FIMBank Sign Alliance Agreement to Boost Corporate Finance
-
Turkish Energy Minister Highlights Qatar as Key Partner for Regional and Global Energy Security
WADA appeals, seeks ban after Sinner cleared in doping case
The World Anti-Doping Agency (WADA) said Saturday that it has appealed to the Court of Arbitration for Sport in the steroid case of tennis world number one Jannik Sinner.
"WADA is seeking a period of ineligibility of between one and two years," it said in a statement, after the Italian twice tested positive for the banned substance clostebol in March but was cleared to carry on playing.
The 23-year-old Sinner, who recently won the US Open for his second Grand Slam title and is currently in action in Beijing, has denied doping.
Last month, the International Tennis Integrity Agency (ITIA) said that Sinner had been cleared of any wrongdoing after twice testing positive earlier in the season.
The ITIA accepted his explanation that the drug entered his system when his physiotherapist used a spray containing it to treat a cut, then provided massage and sports therapy to the player.
WADA said in its statement that it lodged an appeal to CAS, the top court in sport, on Thursday.
"It is WADA's view that the finding of 'no fault or negligence' was not correct under the applicable rules," it said.
It added: "WADA is not seeking a disqualification of any results, save that which has already been imposed by the tribunal of first instance.
"As this matter is now pending before CAS, WADA will make no further comment at this time."
Clostebol is an anabolic agent prohibited at all times by WADA.
After winning the US Open, Sinner said that the controversy over his failed tests was still on his mind.
He defeated Taylor Fritz in straight sets to add the New York title to his Australia Open triumph in January.
"It was and it's still on my mind. It's not that it's gone, but when I'm on court, I try to focus about the game, I try to handle the situation the best possible way, communication with the team, in the practice courts," said the world number one.
"It was not easy, that's for sure, but I tried to stay focused, with which I guess I've done a great job."
The decision to clear the Italian was met with scepticism by some players in the locker room who suggested that Sinner had benefited from preferential treatment due to his status in the sport.
H.Gonzales--AT